Novozymes A/S (VIE:NZYM)

Novozymes Statistics

Total Valuation

Novozymes has a market cap or net worth of EUR 25.43 billion. The enterprise value is 28.42 billion.

Market Cap	25.43B
Enterprise Value	28.42B

Important Dates

The next estimated earnings date is Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	Aug 25, 2025

Share Statistics

Current Share Class	411.85M
Shares Outstanding	n/a
Shares Change (YoY)	-22.70%
Shares Change (QoQ)	+0.77%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	36.69%
Float	346.32M

Valuation Ratios

The trailing PE ratio is 45.04 and the forward PE ratio is 27.53.

PE Ratio	45.04
Forward PE	27.53
PS Ratio	6.21
PB Ratio	2.37
P/TBV Ratio	n/a
P/FCF Ratio	42.59
P/OCF Ratio	27.70
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.62, with an EV/FCF ratio of 47.59.

EV / Earnings	50.33
EV / Sales	6.94
EV / EBITDA	20.62
EV / EBIT	25.66
EV / FCF	47.59

Financial Position

The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.31.

Current Ratio	1.75
Quick Ratio	1.04
Debt / Equity	0.31
Debt / EBITDA	2.40
Debt / FCF	5.56
Interest Coverage	15.48

Financial Efficiency

Return on equity (ROE) is 5.19% and return on invested capital (ROIC) is 5.15%.

Return on Equity (ROE)	5.19%
Return on Assets (ROA)	4.40%
Return on Invested Capital (ROIC)	5.15%
Return on Capital Employed (ROCE)	7.32%
Revenue Per Employee	387,252
Profits Per Employee	53,364
Employee Count	10,582
Asset Turnover	0.26
Inventory Turnover	2.33

Taxes

In the past 12 months, Novozymes has paid 181.60 million in taxes.

Income Tax	181.60M
Effective Tax Rate	24.33%

Stock Price Statistics

The stock price has decreased by -10.04% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-10.04%
50-Day Moving Average	53.64
200-Day Moving Average	56.62
Relative Strength Index (RSI)	55.18
Average Volume (20 Days)	1

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novozymes had revenue of EUR 4.10 billion and earned 564.70 million in profits. Earnings per share was 1.99.

Revenue	4.10B
Gross Profit	2.37B
Operating Income	1.11B
Pretax Income	746.30M
Net Income	564.70M
EBITDA	1.39B
EBIT	1.11B
Earnings Per Share (EPS)	1.99

Balance Sheet

The company has 328.20 million in cash and 3.32 billion in debt, giving a net cash position of -2.99 billion.

Cash & Cash Equivalents	328.20M
Total Debt	3.32B
Net Cash	-2.99B
Net Cash Per Share	n/a
Equity (Book Value)	10.74B
Book Value Per Share	23.07
Working Capital	880.80M

Cash Flow

In the last 12 months, operating cash flow was 918.30 million and capital expenditures -321.10 million, giving a free cash flow of 597.20 million.

Operating Cash Flow	918.30M
Capital Expenditures	-321.10M
Free Cash Flow	597.20M
FCF Per Share	n/a

Margins

Gross margin is 57.72%, with operating and profit margins of 27.21% and 13.78%.

Gross Margin	57.72%
Operating Margin	27.21%
Pretax Margin	18.21%
Profit Margin	13.78%
EBITDA Margin	33.82%
EBIT Margin	27.21%
FCF Margin	14.57%

Dividends & Yields

This stock pays an annual dividend of 0.86, which amounts to a dividend yield of 1.59%.

Dividend Per Share	0.86
Dividend Yield	1.59%
Dividend Growth (YoY)	61.09%
Years of Dividend Growth	n/a
Payout Ratio	68.57%
Buyback Yield	22.70%
Shareholder Yield	24.28%
Earnings Yield	2.22%
FCF Yield	2.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novozymes has an Altman Z-Score of 4.33 and a Piotroski F-Score of 6.

Altman Z-Score	4.33
Piotroski F-Score	6